Organization | El-Sahel Teaching Hospital

El-Sahel Teaching Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial

2016

NCT03318471

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2017

Timeline

NOW

Now

Alternative names

El-Sahel Teaching Hospital | ElSahel Teaching hospital,Cairo

Active Ingredients

Drugs in Phase 4 Trials (4)

magnesium sulfate (Tis-U-Sol) (1 trial)

propofol (diprivan) (1 trial)

sevoflurane (ultane) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Brain Neoplasms (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 2
# of Trial APIs: 4